Wockhardt’s novel antibiotic Zaynich eyes $9 billion global market
Mumbai-based pharma major Wockhardt, which is all set to launch its new class of antibiotic Zaynich targeted at treating complicated gram-negative infections in India this year, estimates that the drug…